Pineapple Express Cannabis (PNXP) Liabilities and Shareholders Equity (2018 - 2025)

Pineapple Express Cannabis' (PNXP) quarterly Liabilities and Shareholders Equity came in at $190000.0 in Q4 2025, down 93.7% year-on-year from $3.0 million in Q4 2024, and little changed quarter-over-quarter from $190000.0 in Q3 2025.

Pineapple Express Cannabis (PNXP) Liabilities and Shareholders Equity (2018 - 2025) Analysis & Trends

Pineapple Express Cannabis has disclosed Liabilities and Shareholders Equity across 8 years of filings, most recently posting $190000.0 for Q4 2025.

  • Liabilities and Shareholders Equity for Q4 2025 came in at $190000.0, down 93.7% year-over-year; the trailing twelve-month figure through Oct 2025 was $570000.0 (down 94.83% YoY), and the FY2024 annual result was $1870.0, down 18.7% from the prior year.
  • Liabilities and Shareholders Equity came in at $190000.0 for Q4 2025 at Pineapple Express Cannabis, roughly flat from $190000.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $5.0 million in Q2 2024 to a low of $1870.0 in Q1 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $32322.0 (2021), against an average of $741529.6.
  • Across the five-year window, Liabilities and Shareholders Equity soared 10109.59% in 2023 and slumped 96.2% in 2025, its largest moves.
  • Pineapple Express Cannabis' Liabilities and Shareholders Equity stood at $18510.0 in 2021, then slumped by 43.06% to $10539.0 in 2022, then jumped by 10109.59% to $1.1 million in 2023, then surged by 180.37% to $3.0 million in 2024, then sank by 93.7% to $190000.0 in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $190000.0 (Q4 2025), $190000.0 (Q3 2025), and $190000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Pineapple Express Cannabis - - - 190,000.00

Historic Data

Download Data
DateValue
Oct 31, 2025 190,000.00
Jul 31, 2025 190,000.00
Apr 30, 2025 190,000.00
Oct 31, 2024 3.02 Mn
Jul 31, 2024 3.01 Mn
Apr 30, 2024 5.00 Mn
Jan 31, 2024 1,870.00
Oct 31, 2023 1.08 Mn
Jul 31, 2023 934,828.00
Apr 30, 2023 324,445.00
Jan 31, 2023 2,300.00
Oct 31, 2022 10,539.00
Jul 31, 2022 11,110.00
Apr 30, 2022 12,354.00
Jan 31, 2022 18,209.00
Oct 31, 2021 18,510.00
Jul 31, 2021 19,537.00
Apr 30, 2021 25,180.00
Jan 31, 2021 32,322.00
Oct 31, 2020 -22,329.00